Literature DB >> 23751022

Clinical significance of vimentin expression and Her-2 status in patients with gastric carcinoma.

Wenwen Zhao1, Lu Yue, Fang Zhou, Congcong Xu, Wanhua Liang, Aihua Sui, Aiping Ding, Wensheng Qiu.   

Abstract

OBJECTIVES: To determine whether vimentin could be used as a marker of gastric carcinomas with more aggressive behavior. To detect the extent of Her-2 status in gastric carcinoma and explore the correlation between vimentin expression and Her-2 status.
METHODS: Vimentin expression was detected in surgically resected gastric carcinoma tissue specimens from 143 patients by immunohistochemistry. The human epidermal growth factor receptor 2 (Her2) status was evaluated by fluorescence in situ hybridization (FISH). Correlations between vimentin expression, Her-2 status and clinicopathological factors were evaluated using Kaplan-Meier method and Cox multivariate survival models.
RESULTS: Vimentin expression was significantly correlated with age, advanced stage, poorly differentiated type, venous invasion, hepatic metastasis, and recurrence (p < 0.05). Her-2 gene was amplified in 16 (11.2%) out of the 143 gastric carcinoma tissue specimens. Her-2 status was correlated with advanced cancer, poor differentiation, venous invasion, hepatic metastasis, and recurrence (p < 0.05). The result of multivariate analysis showed that vimentin expression and lymph node metastasis were independent prognostic factors.
CONCLUSIONS: Vimentin expression in epithelial cells of the surgically resected gastric adenocarcinoma tissue is an independent predictor of short survival, and Her-2 status shows a valuable correlation with clinical parameters.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23751022      PMCID: PMC5350850          DOI: 10.1111/cts.12043

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  25 in total

1.  The clinical significance of vimentin-expressing gastric cancer cells in bone marrow.

Authors:  Masaaki Iwatsuki; Koshi Mimori; Takeo Fukagawa; Hideshi Ishii; Takehiko Yokobori; Mitsuru Sasako; Hideo Baba; Masaki Mori
Journal:  Ann Surg Oncol       Date:  2010-04-01       Impact factor: 5.344

2.  p21Waf1 expression is regulated by nuclear intermediate filament vimentin in neuroblastoma.

Authors:  Xénia Mergui; Marie-Line Puiffe; Dominique Valteau-Couanet; Marc Lipinski; Jean Bénard; Mounira Amor-Guéret
Journal:  BMC Cancer       Date:  2010-09-02       Impact factor: 4.430

3.  Vimentin expression in 98 breast cancers with medullary features and its prognostic significance.

Authors:  S Holck; L Pedersen; T Schiødt; K Zedeler; H Mouridsen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

4.  [Association of HER-2/neu expression with prognosis of gastric cancer].

Authors:  Bin Chen; Rong-cheng Luo; Fei Cui; Xin-yu Qian
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2006-03

Review 5.  HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target.

Authors:  C Gravalos; A Jimeno
Journal:  Ann Oncol       Date:  2008-04-25       Impact factor: 32.976

6.  Transactivation of vimentin by beta-catenin in human breast cancer cells.

Authors:  Christine Gilles; Myriam Polette; Mélanie Mestdagt; Béatrice Nawrocki-Raby; Philippe Ruggeri; Philippe Birembaut; Jean-Michel Foidart
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

7.  Clinicopathological significance of c-erbB-2 protein expression in human gastric carcinoma.

Authors:  M Tateishi; T Toda; Y Minamisono; S Nagasaki
Journal:  J Surg Oncol       Date:  1992-04       Impact factor: 3.454

8.  Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma.

Authors:  Shona H Lang; Catherine Hyde; Ian N Reid; Ian S Hitchcock; Claire A Hart; A A Gordon Bryden; Jean-Marie Villette; Michael J Stower; Norman J Maitland
Journal:  Prostate       Date:  2002-09-01       Impact factor: 4.104

9.  Vimentin: an evaluation of its role as a tumour marker.

Authors:  M Leader; M Collins; J Patel; K Henry
Journal:  Histopathology       Date:  1987-01       Impact factor: 5.087

10.  Sumoylation of vimentin354 is associated with PIAS3 inhibition of glioma cell migration.

Authors:  Liming Wang; Jian Zhang; Sipra Banerjee; Laura Barnes; Laura Barnes; Venkateswara Sajja; Yiding Liu; Baochuan Guo; Yuping Du; Mukesh K Agarwal; David N Wald; Qin Wang; Jinbo Yang
Journal:  Oncotarget       Date:  2010-11
View more
  5 in total

Review 1.  Pathophysiological Role of Vimentin Intermediate Filaments in Lung Diseases.

Authors:  Ranu Surolia; Veena B Antony
Journal:  Front Cell Dev Biol       Date:  2022-04-28

2.  The siRNA cocktail targeting VEGF and HER2 inhibition on the proliferation and induced apoptosis of gastric cancer cell.

Authors:  Kun Liu; Honglin Chen; Qingsheng You; Hai Shi; Zhiwei Wang
Journal:  Mol Cell Biochem       Date:  2013-10-26       Impact factor: 3.396

Review 3.  Emerging evidence of the molecular landscape specific for hematogenous metastasis from gastric cancer.

Authors:  Dai Shimizu; Mitsuro Kanda; Yasuhiro Kodera
Journal:  World J Gastrointest Oncol       Date:  2018-06-15

4.  CORO1C expression is associated with poor survival rates in gastric cancer and promotes metastasis in vitro.

Authors:  Xiao Cheng; Xiaonan Wang; Zhengsheng Wu; Sheng Tan; Tao Zhu; Keshuo Ding
Journal:  FEBS Open Bio       Date:  2019-04-29       Impact factor: 2.693

5.  Evasion of NK cell immune surveillance via the vimentin-mediated cytoskeleton remodeling.

Authors:  Jei-Ming Peng; Ching-Feng Chiu; Jai-Hong Cheng; Hui-Ying Liu; Yin-Lun Chang; Jia-Wun Luo; Yu-Ting Weng; Hao-Lun Luo
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.